Laurence Zitvogel

Laurence Zitvogel at Gustave Roussy has made major contributions to cancer immunology, including establishing immunogenic cell death (ICD) as a mechanism by which certain chemotherapy agents trigger anti-tumor immune responses. Her landmark research demonstrating that the gut microbiome influences response to checkpoint immunotherapy has opened new avenues for improving immunotherapy outcomes through microbiome modulation.